MATT ABERNETHY Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MATT ABERNETHY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MATT ABERNETHY. MATT ABERNETHY is Chief Financial Officer in NEUROCRINE BIOSCIENCES INC ($NBIX).
Latest Insider Trading Transactions of MATT ABERNETHY
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 7,439 | 0 | 7,439 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 117.63 | 44,632 | 5,250,062 | 44,632 | |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 116.81 | 2,030 | 237,116 | 14,869 | 16.9 K to 14.9 K (-12.01 %) |
| Feb 09 2021 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 116.85 | 880 | 102,826 | 13,043 | 13.9 K to 13 K (-6.32 %) |
| Dec 02 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 94.66 | 1,645 | 155,721 | 11,494 | 13.1 K to 11.5 K (-12.52 %) |
| Nov 16 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 90.74 | 2,257 | 204,810 | 10,014 | 12.3 K to 10 K (-18.39 %) |
| Aug 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 118.90 | 2,257 | 268,356 | 7,983 | 10.2 K to 8 K (-22.04 %) |
| May 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | M | 73.60 | 15,000 | 1,104,000 | 45,000 | |
| May 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 110.21 | 15,000 | 1,653,134 | 5,953 | 21 K to 6 K (-71.59 %) |
| May 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Buy | M | 73.60 | 15,000 | 1,104,000 | 20,953 | 6 K to 21 K (+251.97 %) |
| Apr 30 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 102.49 | 1,741 | 178,435 | 5,953 | 7.7 K to 6 K (-22.63 %) |
| Apr 28 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 99.52 | 1,934 | 192,467 | 7,694 | 9.6 K to 7.7 K (-20.09 %) |
| Feb 11 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 103.35 | 2,030 | 209,807 | 5,701 | 7.7 K to 5.7 K (-26.26 %) |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 9,719 | 0 | 9,719 | |
| Feb 07 2020 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 102.90 | 61,347 | 6,312,606 | 61,347 | |
| Dec 04 2019 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 116.33 | 1,645 | 191,360 | 3,876 | 5.5 K to 3.9 K (-29.80 %) |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 15,423 | 0 | 15,423 | |
| Feb 08 2019 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 81.05 | 83,341 | 6,754,788 | 83,341 | |
| Dec 06 2018 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Sell | S | 90.00 | 1,178 | 106,020 | 1,947 | 3.1 K to 1.9 K (-37.70 %) |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
| Feb 07 2018 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,250 | 0 | 12,250 | |
| Dec 05 2017 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 0.00 | 12,500 | 0 | 12,500 | |
| Dec 05 2017 | NBIX | NEUROCRINE BIOSCIE ... | ABERNETHY MATT | Chief Financial Off ... | Option Exercise | A | 73.60 | 60,000 | 4,416,000 | 60,000 |
Page: 1